|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
255,869 |
290,136 |
408,483 |
778,755 |
Total Sell Value |
$98,735,492 |
$109,899,457 |
$146,089,202 |
$238,758,936 |
Total People Sold |
8 |
9 |
12 |
12 |
Total Sell Transactions |
23 |
30 |
43 |
68 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rubash Mark J |
Director |
|
2023-04-28 |
4 |
OE |
$71.32 |
$1,372,015 |
D/D |
7,323 |
16,005 |
|
- |
|
Kania Don R |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
3,269 |
|
- |
|
Leonard Keith R |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
3,584 |
|
- |
|
Johnson Amal M |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
11,706 |
|
- |
|
Barratt Craig H |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
655 |
25,351 |
|
- |
|
Rubash Mark J |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
15,482 |
|
- |
|
Ladd Amy L |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
1,202 |
|
- |
|
Reed Monica P |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
1,037 |
|
- |
|
Levy Alan J |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
25,319 |
|
- |
|
Berry Joseph C |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
1,802 |
|
- |
|
Nachtsheim Jami K |
Director |
|
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
5,063 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-04-24 |
4 |
AS |
$299.20 |
$12,196,446 |
D/D |
(40,764) |
155,712 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-04-24 |
4 |
OE |
$42.64 |
$2,302,382 |
D/D |
54,000 |
196,476 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2023-04-21 |
4 |
AS |
$297.87 |
$187,658 |
D/D |
(630) |
2,233 |
|
- |
|
Rubash Mark J |
Director |
|
2023-04-21 |
4 |
AS |
$297.89 |
$2,423,689 |
D/D |
(8,135) |
15,000 |
|
- |
|
Rubash Mark J |
Director |
|
2023-04-21 |
4 |
OE |
$90.49 |
$1,134,862 |
D/D |
8,135 |
15,927 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-04-21 |
4 |
AS |
$297.92 |
$12,155,173 |
D/D |
(40,800) |
142,476 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-04-21 |
4 |
OE |
$42.64 |
$2,302,382 |
D/D |
54,000 |
183,276 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2023-04-21 |
4 |
AS |
$297.90 |
$2,568,981 |
D/D |
(8,623) |
7,065 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2023-04-21 |
4 |
OE |
$177.99 |
$1,407,768 |
D/D |
6,260 |
11,872 |
|
- |
|
Barratt Craig H |
Director |
|
2023-04-21 |
4 |
AS |
$297.92 |
$1,787,524 |
D/D |
(6,000) |
0 |
|
- |
|
Barratt Craig H |
Director |
|
2023-04-21 |
4 |
OE |
$41.26 |
$247,547 |
D/D |
6,000 |
2,000 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2023-04-21 |
4 |
AS |
$297.92 |
$2,884,579 |
D/D |
(9,623) |
327 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2023-04-21 |
4 |
OE |
$166.62 |
$1,378,787 |
D/D |
8,000 |
7,950 |
|
- |
|
Rubash Mark J |
Director |
|
2023-04-21 |
4 |
AS |
$297.89 |
$501,401 |
D/D |
(1,683) |
15,000 |
|
- |
|
2128 Records found
|
|
Page 7 of 86 |
|
|